A detailed history of Whitener Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Whitener Capital Management, Inc. holds 6,763 shares of AMGN stock, worth $1.89 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
6,763
Previous 6,963 2.87%
Holding current value
$1.89 Million
Previous $2.18 Million 0.18%
% of portfolio
0.62%
Previous 0.66%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$309.38 - $337.38 $61,876 - $67,476
-200 Reduced 2.87%
6,763 $2.18 Million
Q2 2024

Jul 17, 2024

BUY
$262.75 - $319.31 $5,780 - $7,024
22 Added 0.32%
6,963 $2.18 Million
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $10,217 - $12,333
38 Added 0.55%
6,941 $1.97 Million
Q4 2023

Jan 10, 2024

SELL
$255.7 - $288.46 $3,835 - $4,326
-15 Reduced 0.22%
6,903 $1.99 Million
Q3 2023

Nov 02, 2023

BUY
$218.65 - $271.46 $12,463 - $15,473
57 Added 0.83%
6,918 $1.86 Million
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $21,855 - $25,843
-102 Reduced 1.46%
6,861 $1.52 Million
Q1 2023

Apr 12, 2023

SELL
$225.79 - $275.2 $16,934 - $20,640
-75 Reduced 1.07%
6,963 $1.68 Million
Q4 2022

Mar 01, 2023

BUY
$229.03 - $291.01 $18,093 - $22,989
79 Added 1.14%
7,038 $1.85 Million
Q3 2022

Oct 28, 2022

SELL
$224.46 - $253.15 $50,054 - $56,452
-223 Reduced 3.1%
6,959 $1.57 Million
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $15,918 - $17,715
-69 Reduced 0.95%
7,182 $1.75 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $12,059 - $13,341
55 Added 0.76%
7,251 $1.75 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $1.43 Million - $1.64 Million
7,196 New
7,196 $1.62 Million
Q4 2021

Feb 07, 2022

SELL
$198.88 - $227.6 $1.17 Million - $1.34 Million
-5,900 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $50,520 - $59,190
-238 Reduced 3.88%
5,900 $1.36 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $55,592 - $61,675
238 Added 4.03%
6,138 $1.5 Million
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $454,830 - $541,622
-2,102 Reduced 26.27%
5,900 $1.36 Million
Q3 2020

Oct 09, 2020

SELL
$234.65 - $260.95 $168,948 - $187,884
-720 Reduced 8.25%
8,002 $2.03 Million
Q2 2020

Jul 17, 2020

BUY
$197.81 - $242.74 $9,890 - $12,137
50 Added 0.58%
8,722 $2.06 Million
Q1 2020

Apr 24, 2020

SELL
$182.24 - $241.7 $31,709 - $42,055
-174 Reduced 1.97%
8,672 $1.76 Million
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $23,678 - $28,372
-136 Reduced 1.51%
8,846 $1.71 Million
Q2 2019

Aug 02, 2019

BUY
$166.7 - $195.41 $435,086 - $510,020
2,610 Added 40.96%
8,982 $1.66 Million
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $333,705 - $376,158
-1,845 Reduced 22.45%
6,372 $1.21 Million
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $358,584 - $418,582
2,010 Added 32.38%
8,217 $1.6 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $55,957 - $63,084
302 Added 5.11%
6,207 $1.29 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $6,974 - $7,833
42 Added 0.72%
5,905 $1.09 Million
Q1 2018

Apr 23, 2018

BUY
$169.43 - $198.0 $331,743 - $387,684
1,958 Added 50.14%
5,863 $999,000
Q4 2017

Apr 23, 2018

BUY
$168.79 - $188.59 $659,124 - $736,443
3,905
3,905 $679,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Whitener Capital Management, Inc. Portfolio

Follow Whitener Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whitener Capital Management, Inc. with notifications on news.